Detail Indonesian Drug Policy And Patent Regulation After The TRIPS Agreement: Better Access to Essential Medicines? (This Paper was Presented at The 4th Asian Law Institute Conference 24-25 May 2007, Depok, Indonesia) Bibliografi Author: Utomo, Tomi Suryo Topik: Indonesian Drug Policy; Patent Regulation; drug pricing; public health policy; distribution system; surveillance of prescribing patterns; TRIPS safeguards; protection for pharmaceuticals Bahasa: (EN )     Penerbit: Lembaga Pengkajian Hukum International - Fakultas Hukum Universitas Indonesia     Tempat Terbit: Depok    Tahun Terbit: 2007     Jenis: Papers/Makalah - pada seminar internasional Fulltext: Tomi Suryo Utomo.pdf (234.21KB; 3 download) Abstract This paper examines the impact of patent protection for pharmaceuticals on access to medicines in Indonesia. It focuses on two issues: 1) How do patents affect drug prices? 2) What strategies are recommended for Indonesia to improve access to medicines? A literature review was done to gain background information about the the Indonesian drug policy, patent regulation and problems of access to essential medicines in Indonesia. Information was derived from surveys and interviews with government agencies, pharmaceutical manufacturing officials and government regulatory institutions. Drug checklists were used to record information about patented and non-patented study drugs. The main finding of this paper is that in Indonesian pharmacies the price of patented drugs is 70%-90% higher than non-branded generics and 10-90% higher than branded generics. This paper acknowledges the importance of additional factors (e.g. public health policy, drug pricing, distribution system, and surveillance of prescribing patterns) besides patent law that affect access to medicines. Although these factors are outside the scope of this paper, they illustrate the need to involve a multi-sectoral group of policymakers and stakeholders to improve access to medicines in Indonesia. The overall recommendation is that the Indonesian government should take advantage of TRIPS safeguards, such as parallel imports, compulsory licenses, bolar provisions and government use. To support the use of safeguards, this thesis offers specific recommendation intended to remove ambiguities in current regulations and to fill gaps in Indonesia’s patent law legislation. Opini Anda Klik untuk menuliskan opini Anda tentang koleksi ini! Lihat Sejarah Pengadaan  Konversi Metadata   Kembali

Copyright © 2006, 2007 Unika Atma Jaya, all rights reserved